Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection
Natalia Sherina, Antonio Piralla, Likun Du, et al.
Med (2021) Vol. 2, Iss. 3, pp. 281-295.e4
Open Access | Times Cited: 192

Showing 1-25 of 192 citing articles:

T cell response to SARS-CoV-2 infection in humans: A systematic review
Madhumita Shrotri, May C I van Schalkwyk, Nathan Post, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0245532-e0245532
Open Access | Times Cited: 351
Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant
Venkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 516-521.e3
Open Access | Times Cited: 235
SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells
Jae Hyung Jung, Min‐Seok Rha, Moa Sa, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 217
Activation or exhaustion of CD8+ T cells in patients with COVID-19
Min‐Seok Rha, Eui‐Cheol Shin
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2325-2333
Open Access | Times Cited: 164
SARS-CoV-2-specific T cells in infection and vaccination
Antonio Bertoletti, Nina Le Bert, Martin Qui, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2307-2312
Open Access | Times Cited: 150
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
Fanglei Zuo, Hassan Abolhassani, Likun Du, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 137
Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals
Anthony T. Tan, Joey Ming Er Lim, Nina Le Bert, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 17
Open Access | Times Cited: 116
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
Karen Colwill, Yannick Galipeau, Matthew Stuible, et al.
Clinical & Translational Immunology (2022) Vol. 11, Iss. 3
Open Access | Times Cited: 105
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
Jan Van Elslande, Matthijs Oyaert, Natalie Lorent, et al.
Diagnostic Microbiology and Infectious Disease (2022) Vol. 103, Iss. 1, pp. 115659-115659
Open Access | Times Cited: 73
Immunity to SARS-CoV-2 up to 15 months after infection
Harold Marcotte, Antonio Piralla, Fanglei Zuo, et al.
iScience (2022) Vol. 25, Iss. 2, pp. 103743-103743
Open Access | Times Cited: 68
The role of immune activation and antigen persistence in acute and long COVID
Skye Opsteen, Jacob K. Files, Tim Fram, et al.
Journal of Investigative Medicine (2023) Vol. 71, Iss. 5, pp. 545-562
Open Access | Times Cited: 40
Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy
Marwa O. Elgendy, Mohamed E. A. Abdelrahim
Journal of Medical Virology (2021) Vol. 93, Iss. 12, pp. 6535-6543
Open Access | Times Cited: 92
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
Gregory Milne, Thomas Hames, Chris J. Scotton, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 12, pp. 1450-1466
Open Access | Times Cited: 78
SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors
Evangelos Terpos, Dimitris Stellas, Margherita Rosati, et al.
European Journal of Internal Medicine (2021) Vol. 89, pp. 87-96
Open Access | Times Cited: 63
Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses
Jacob K. Files, Sanghita Sarkar, Timothy Fram, et al.
JCI Insight (2021)
Open Access | Times Cited: 62
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome
Hassan Abolhassani, Nils Landegren, Paul Bastard, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 3, pp. 471-483
Open Access | Times Cited: 60
The potential clinical utility of measuring severe acute respiratory syndrome coronavirus 2-specific T-cell responses
Delia Goletti, Linda Petrone, Davide Manissero, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 12, pp. 1784-1789
Open Access | Times Cited: 59
The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
Esther Moga, Elionor Lynton-Pons, Peré Domingo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 44
Decline of Humoral and Cellular Immune Responses Against SARS-CoV-2 6 Months After Full BNT162b2 Vaccination in Hospital Healthcare Workers
Benjamin Bonnet, Hélène Chabrolles, Christine Archimbaud, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants
Wanbo Tai, Shengyong Feng, Benjie Chai, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Persistence and baseline determinants of seropositivity and reinfection rates in health care workers up to 12.5 months after COVID-19
Carlota Dobaño, Anna Ramírez‐Morros, Selena Alonso, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 48
Landscape and selection of vaccine epitopes in SARS-CoV-2
Christof C. Smith, Kelly Olsen, Kaylee M. Gentry, et al.
Genome Medicine (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 48
Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant
Venkata Viswanadh Edara, Carson Norwood, Katharine Floyd, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 42
SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
John Tyler Sandberg, Renata Varnaitė, Wanda Christ, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 7
Open Access | Times Cited: 40
X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia
Hassan Abolhassani, Ahmad Vosughimotlagh, Takaki Asano, et al.
Journal of Clinical Immunology (2021) Vol. 42, Iss. 1, pp. 1-9
Open Access | Times Cited: 40
Page 1 - Next Page

Scroll to top